Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL223119 | 0.91 | — | — | |
| SCHEMBL10926007 | 0.88 | CYP1A2 (0.44) | ALDH1A1KDM4EHPGDCYP1A2CYP2D6 | |
| SCHEMBL8663867 | 0.88 | CYP1A2 (0.44) | ALDH1A1KDM4EHPGDCYP1A2CYP2D6 | |
| SCHEMBL16161159 | 0.88 | CYP1A2 (0.44) | ALDH1A1KDM4EHPGDCYP1A2CYP2D6 | |
| SCHEMBL8679600 | 0.88 | — | — | |
| SCHEMBL3679794 | 0.88 | — | — | |
| SCHEMBL8130138 | 0.88 | CYP1A2 (0.44) | ALDH1A1KDM4EHPGDCYP1A2CYP2D6 | |
| SCHEMBL8660949 | 0.88 | CYP1A2 (0.44) | ALDH1A1KDM4EHPGDCYP1A2CYP2D6 | |
| SCHEMBL11673737 | 0.82 | TSHR (0.42) | ALDH1A1TSHRTDP1CYP3A4PTPN1 | |
| SCHEMBL20597208 | 0.82 | TSHR (0.42) | ALDH1A1TSHRTDP1CYP3A4PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030224038-A1 | Cross-linkable phosphonate-containing supramolecular complexes and their use for delivery of therapeutic and diagnostic agents | PAGE CATHERINE J (US) | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030224038-A1 | Cross-linkable phosphonate-containing supramolecular complexes and their use for delivery of therapeutic and diagnostic agents | PHOSPHO1, PPIP5K2, CLTB | ALDH1A1 4588/4885KDM4E 4538/4885HPGD 1606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.